• Please log in or register to access this feature.

Clinical and Laboratory Investigation

You have free access to this content

Propranolol Use in PHACE Syndrome with Cervical and Intracranial Arterial Anomalies: Collective Experience in 32 Infants

  1. Denise Metry M.D.1,2,*,
  2. Ilona J. Frieden M.D.3,4,
  3. Christopher Hess M.D., Ph.D.5,
  4. Dawn Siegel M.D.6,7,
  5. Mohit Maheshwari M.D.8,
  6. Eulalia Baselga M.D.9,
  7. Sarah Chamlin M.D.10,11,
  8. Maria Garzon M.D.12,13,
  9. Anthony J. Mancini M.D.10,11,
  10. Julie Powell M.D.14,15,
  11. Beth A. Drolet M.D.16,17

Article first published online: 20 SEP 2012

DOI: 10.1111/j.1525-1470.2012.01879.x

Issue

Pediatric Dermatology

Pediatric Dermatology

Volume 30, Issue 1, pages 71–89, January/February 2013

Additional Information

How to Cite

Metry, D., Frieden, I. J., Hess, C., Siegel, D., Maheshwari, M., Baselga, E., Chamlin, S., Garzon, M., Mancini, A. J., Powell, J. and Drolet, B. A. (2013), Propranolol Use in PHACE Syndrome with Cervical and Intracranial Arterial Anomalies: Collective Experience in 32 Infants. Pediatric Dermatology, 30: 71–89. doi: 10.1111/j.1525-1470.2012.01879.x

Author Information

  1. 1

    Department of Dermatology, Baylor College of Medicine, Houston, Texas

  2. 2

    Department of Pediatrics, Baylor College of Medicine, Houston, Texas

  3. 3

    Department of Dermatology, University of California at San Francisco, San Francisco, California

  4. 4

    Department of Pediatrics, University of California at San Francisco, San Francisco, California

  5. 5

    Department of Radiology and Biomedical Imaging, University of California at San Francisco, San Francisco, California

  6. 6

    Department of Dermatology, Medical College of Wisconsin, Barcelona, Spain

  7. 7

    Department of Pediatrics, Medical College of Wisconsin, Barcelona, Spain

  8. 8

    Department of Radiology, Medical College of Wisconsin, Barcelona, Spain

  9. 9

    Department of Dermatology, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain

  10. 10

    Department of Dermatology, Feinberg School of Medicine, Children's Memorial Hospital, Northwestern University, Evanston, Illinois

  11. 11

    Department of Pediatrics, Feinberg School of Medicine, Children's Memorial Hospital, Northwestern University, Evanston, Illinois

  12. 12

    Department of Dermatology, Columbia University, New York, New York

  13. 13

    Department of Pediatrics, Columbia University, New York, New York

  14. 14

    Department of Dermatology, CHU Sainte Justine, University of Montreal, Montreal, Quebec, Canada

  15. 15

    Department of Pediatrics, CHU Sainte Justine, University of Montreal, Montreal, Quebec, Canada

  16. 16

    Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin

  17. 17

    Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin

*Address correspondence to Denise Metry, M.D., Department of Dermatology and Pediatrics, Texas Children's Hospital, 6621 Fannin St., CC620.16, Houston, TX 77030, or e-mail: dmetry@bcm.edu.

Publication History

  1. Issue published online: 15 JAN 2013
  2. Article first published online: 20 SEP 2012

Funded by

  • National Institutes of Health
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases. Grant Number: 1R34AR060881–01

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (244K)

References

  • 1
    Kilcline C, Frieden IJ. Infantile hemangiomas: how common are they? A systematic review of the literature. Pediatr Dermatol 2008;25:168–173.
    Direct Link:
  • 2
    Leaute-Labrèze C, Dumas de la Roque E, Hubiche T et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649–2651.
  • 3
    Frieden IJ, Reese V, Cohen D. PHACE syndrome: the association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects and eye abnormalities. Arch Dermatol 1996;132:307–311.
  • 4
    Haggstrom AN, Garzon MC, Baselga E et al. Risk for PHACE syndrome in infants with large facial hemangiomas. Pediatrics 2010;126:418–426.
  • 5
    Burrows PE, Robertson RL, Mulliken JB et al. Cerebral vasculopathy and neurologic sequelae in infants with cervicofacial hemangioma: report of eight patients. Radiology 1998;207:601–607.
  • 6
    Drolet BA, Dohil M, Golomb MR et al. Early stroke and cerebral vasculopathy in children with facial hemangiomas and PHACE association. Pediatrics 2006;117:959–964.
  • 7
    Siegel DH, Tefft KA, Johnson C et al. Stroke in children with PHACE syndrome: a systematic review of the literature. Stroke 2012;43:1672–1674.
  • 8
    Rao RP, Drolet BA, Holland KE et al. PHACES association: a vasculocutaneous syndrome. Pediatr Cardiol 2008;29:793–799.
  • 9
    Dobkin BH. Orthostatic hypotension as a risk factor for symptomatic occlusive cerebrovascular disease. Neurology 1989;39:30–34.
  • 10
    Iwama T, Hashimoto N, Yonekawa Y. The relevance of hemodynamic factors to perioperative ischemic complications in childhood moyamoya disease. Neurosurgery 1996;38:1120–1125.
  • 11
    Novak V, Hu K, Desrochers L et al. Cerebral flow velocities during daily activities depend on blood pressure in patients with chronic ischemic infarctions. Stroke 2010;41:61–66.
  • 12
    Chou PS, Guo YC. Limb-shaking transient ischemic attacks in an adult PHACE syndrome: a case report and review of the literature. Neurol Sci 2011;33:305–307.
  • 13
    Metry D, O'Conner S, Drolet BA. Migraine-like headaches in PHACE syndrome. (in press).
  • 14
    Metry DW, Garzon MC, Drolet BA et al. PHACE syndrome: current knowledge, future directions. Pediatr Dermatol 2009;26:381–398.
    Direct Link:
  • 15
    Brandling-Bennett HA, Metry DW, Baselga E et al. Infantile hemangiomas with unusually prolonged growth phase: a case series. Arch Dermatol 2008;144:1632–1637.
  • 16
    Drolet BA, Pope E, Juern AM et al. Gastrointestinal bleeding in infantile hemangioma: a complication of segmental, rather than multifocal, infantile hemangiomas. J Pediatr 2012;160:1021–1026.e3.
  • 17
    Durr ML, Meyer AK, Huoh KC et al. Airway hemangiomas in PHACE syndrome. Laryngoscope 2012 (in press).
    Direct Link:
  • 18
    Haggstrom AN, Skillman S, Garzon MC et al. Clinical spectrum and risk of PHACE syndrome in cutaneous and airway hemangiomas. Arch Otolaryngol Head Neck Surg 2011;137:680–687.
  • 19
    Hess CP, Fullerton HJ, Metry DW et al. Cervical and intracranial arterial anomalies in 70 patients with PHACE syndrome. AJNR Am J Neuroradiol 2010;31:1980–1986.
  • 20
    Poindexter G, Metry DW, Barkovich AJ et al. PHACE syndrome with intracerebral hemangiomas, heterotopia, and endocrine dysfunction. Pediatr Neurol 2007;36:402–406.
  • 21
    Rosbe KW, Suh KY, Meyer AK et al. Propranolol in the management of airway infantile hemangiomas. Arch Otolaryngol Head Neck Surg 2010;136:658–665.
  • 22
    Suh KY, Rosbe KW, Meyer AK et al. Extensive airway hemangiomas in two patients without beard hemangiomas. Pediatr Dermatol 2011;28:347–348.
    Direct Link:
  • 23
    Metry D, Heyer G, Hess C et al. Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics 2009;124:1447–1456.
  • 24
    Haggstrom AN, Lammer EJ, Schneider RA et al. Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 2006;117:698–703.
  • 25
    Beslow LA, Jordan LC. Pediatric stroke: the importance of cerebral arteriopathy and vascular malformations. Childs Nerv Syst 2010;26:1263–1273.
  • 26
    Johnson BA, Heiserman JE, Drayer BP et al. Intracranial MR angiography: its role in the integrated approach to brain infarction. AJNR Am J Neuroradiol 1994;15:901–908.
  • 27
    Vasaiwala R, Saija K, Setabutr P. Novel management of the microphthalmic orbit in a patient with PHACE syndrome. Ophthal Plast Reconstr Surg 2011;27:156–158.
  • 28
    Solomon T, Ninnis J, Deming D et al. Use of propranolol for treatment of hemangiomas in PHACE syndrome. J Perinatol 2011;31:739–741.
  • 29
    Manunza F, Syed S, Laguda B et al. Propranolol for complicated infantile hemangiomas: a case series of 30 infants. Br J Dermatol 2010;162:466–468.
    Direct Link:
  • 30
    Hernandez-Martin S, Lopez-Gutierrez JC, Lopez-Fernandez S et al. Brain perfusion SPECT in patients with PHACES syndrome under propranolol treatment. Eur J Pediatr Surg 2011;22:54–59.
  • 31
    Johnston GD, Finch MB, Shanks RG. Peripheral vascular effects of bufuralol in hypertensive and normal subjects: a comparison with propranolol and pindolol. Eur J Clin Pharmacol 1986;30:649–652.
  • 32
    Joint Formulary Committee. British national formulary, Vol. 54. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2007.
  • 33
    Stringer MD, Bentley PG. Peripheral gangrene associated with β-blockade. Br J Surg 1986;73:1008.
    Direct Link:
  • 34
    Vale JA, Jefferys DB. Peripheral gangrene complicating beta-blockade. Lancet 1978;1:1216.
  • 35
    Maguiness SM, Hoffman WY, McCalmont TH et al. Early white discoloration of infantile hemangioma: a sign of impending ulceration. Arch Dermatol 2010;146:1235–1239.
  • 36
    Hermans DJ, van Baynum IM, Schultze Kool LJ et al. Propranolol, a very promising treatment of ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls. J Am Acad Dermatol 2011;64:833–838.
  • 37
    Webb AJ, Fischer U, Rothwell PM. Effects of β-blocker selectivity on blood pressure variability and stroke: a systematic review. Neurology 2011;77:731–737.
  • 38
    Reiter MJ. Cardiovascular drug class specificity: β-blockers. Prog Cardiovasc Dis 2004;47:11–33.
  • 39
    Webb AJS, Fischer U, Mehta Z et al. Effects of antihypertensive-drug class on interindividual variation in BP and risk of stroke: a systematic review and meta-analysis. Lancet 2010;375:906–915.
  • 40
    Schurks M, Rist PM, Bigal ME et al. Migraine and cardiovascular disease: systematic review and meta-analysis. Br Med J 2009;339:b3914.
  • 41
    Alvarez Sabin J, Molins A, Turón A et al. [Migraine-infarct in patients treated with β-blockers.] Rev Clin Esp 1993;192:228–230.
  • 42
    Mendizabal JE, Greiner F, Hamilton DO et al. Migrainous stroke causing thalamic infarction and amnesia during treatment with propranolol. Headache 1997;37:594–596.
    Direct Link:
  • 43
    Bardwell A, Trott JA. Stroke in migraine as a consequence of propranolol. Headache 1987;27:381–383.
    Direct Link:
View Full Article (HTML) Get PDF (244K)